Concepedia

Manoranjan Panda

MP

Statistics

Publications

32

Citations

1.6K

H-Index

25

Active since

1998

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

University of Pennsylvania

AstraZeneca (United States)

École Polytechnique Fédérale de Lausanne

Manoranjan Panda is an author at AstraZeneca (India) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1998–2022

32

Publications

32

Discovery of Imidazo[1,2-<i>a</i>]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis

Subramanyam J. Tantry, Shankar D. Markad, Vikas Shinde et al. · Journal of Medicinal Chemistry · 2017 · 126 citations

, , +17

Ground and Excited State Intramolecular Proton Transfer in Salicylic Acid:  an Ab Initio Electronic Structure Investigation

Shruti Maheshwari, Arindam Chowdhury, N. Sathyamurthy et al. · The Journal of Physical Chemistry A · 1999 · 124 citations

, , +17

Quantum Mechanical Models Correlating Structure with Selectivity:  Predicting the Enantioselectivity of β-Amino Alcohol Catalysts in Aldehyde Alkylation

Marisa C. Kozlowski, Steven L. Dixon, Manoranjan Panda et al. · Journal of the American Chemical Society · 2003 · 106 citations

, , +17

Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis

Pravin S. Shirude, Prashanti Madhavapeddi, Maruti Naik et al. · Journal of Medicinal Chemistry · 2013 · 101 citations · Full text

, , +17

4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity

Maruti Naik, Vaishali Humnabadkar, Subramanyam J. Tantry et al. · Journal of Medicinal Chemistry · 2014 · 94 citations · Full text

, , +16

1–5 of 32